Treatment with Neu5Gc has been shown to promote the proliferation of both colorectal cancer cells and normal intestinal epithelial cells, associated with increased levels of HRAS, CCNA2 (Cyclin A2), and AKT2 proteins [80]. Here, CCNA2 is linked to colorectal cancer.